PT - JOURNAL ARTICLE AU - Tiziana Fernández-Mincone AU - Macarena Viñuela Morales AU - Marco Arrese Jiménez AU - Juan Pablo Arab Verdugo AU - Daniel Cabrera AU - Francisco Barrera Martínez TI - LIFESTYLE CHANGES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW PROTOCOL AID - 10.1101/2020.06.22.20137430 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.22.20137430 4099 - http://medrxiv.org/content/early/2020/06/23/2020.06.22.20137430.short 4100 - http://medrxiv.org/content/early/2020/06/23/2020.06.22.20137430.full AB - Non-alcoholic fatty liver disease (NAFLD) is a worldwide raising liver condition and it is expected to become the first cause of progression to cirrhosis and hepatocellular carcinoma in the next 5 years (Araújo 2018). At present, there are no pharmacological treatments approved. Weight loss is the first-line treatment (European Association for the Study of the Liver 2016) (Chalasani 2012) showing that 7 to 10% weight loss improves steatosis, inflammation, hepatocyte ballooning and, in NASH patients, has an impact in fibrosis too (Romero-Gómez 2017). However, the reduction and maintenance of weight loss is often complex. To achieve this goal, it is recommended doing lifestyle changes including exercise and diet on daily living (Hannah 2016). However, it has been difficult to establish any conclusions regarding the best type of diet or exercise protocol to maximize improvements and to maintain its effects through time. Because of this, the objective of this review is assessing the efficacy and safety of diet, exercise, or a combination of these in patients with NAFLD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis manuscript is support by FONDECYT Chile grant number 1191183Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:does not applyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the information included in this manuscript is referenced in previous publications